20,000-square-foot site increases Endo’s sterile injectable production capacity This marks the site’s first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions
MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use
Endo focuses on developing and delivering specialty pharmaceutical products — many of which are complex in nature and require unique expertise, technology, and equipment. We focus on medical
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the
ASHP Midyear 2024 Clinical Meeting & Exhibition December 7 – 12, 2024 | New Orleans, LA Featuring some of the most innovative technologies and products,
NACDS Total Store Expo 2024 August 17 – 19, 2024 | Boston, MA Discover new and innovative products, technology and services and find the partners
MALVERN, Pa., July 15, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics’
McKesson ideaShare 2024 | June 23 – 26, 2024 | New Orleans, LA “McKesson ideaShare is the nation’s premier community pharmacy event that empowers current